| |
Neural EnvironmentScientific Area of ResearchNeurological disorders may result when extra-neuronal cells are compromised, as in demyelinating and cerebrovascular diseases; when extra-neuronal cells themselves become aggressors, as in inflammatory responses within the nervous system, when viruses, bacteria, or parasites infect the cells of the nervous system, when autoimmune responses damage nerve and muscle; when cells of the blood-brain barrier are dysfunctional, or when glial dysfunction in the developing nervous system results in developmental abnormalities. Glial cells, microvascular endothelia, and cells of hematopoetic origin are integrally involved in the normal development and/or functioning of the nervous system and play a crucial role in disease. Emerging concepts on the interaction among all of these cells hold great promise for increasing our understanding of how the nervous system works in normal and diseased states, and will broaden our perspective on how we think about the nervous system.
The Neural Environment cluster promotes translating scientific knowledge into useful diagnostic tools, research on the implementation of preventive measures, and development and delivery of targeted therapeutic agents for neurological diseases.Funding OpportunitiesCurrent Neural Environment Funding Announcements Archived Neural Environment Funding AnnouncementsAdditional InformationMission:
The mission of the Neural Environment Cluster is to reduce the burden of neurological diseases by facilitating research that increases knowledge of glial and cerebrovascular cell function in normal and pathological states, as well as immune cell function and infectious agents in the diseased nervous system. The NINDS Neural Environment Cluster facilitates research on the neural environment by: - Encouraging studies on the development and normal functions of glial cells including myelin formation, microglial function, astrocyte function and cell-cell communication among the diverse cell populations of the nervous system.
- Encouraging research on infectious, immune and inflammatory mechanisms in nervous system disorders such as multiple sclerosis, prion diseases, stroke and neuroAIDS.
- Encouraging studies to identify the molecular mechanisms of cell injury and death in the nervous system
- Fostering studies on vascular mechanisms of neurological disorders, CNS vascular development and the role of microvascular endothelia, extracellular matrix and cells of hematopoetic origin within the central nervous system.
- Promoting the development of diagnostics and of therapies that will prevent, arrest or reverse autoimmune neurological disorders such as multiple sclerosis.
- Expanding studies on the mechanisms of blood-brain and brain-CSF barrier functions and of cell migration (and/or trafficking) into the CNS in stroke, immune disorders and CNS infections.
- Encouraging the development of animal models for infectious and immune disorders, and stroke (e.g. transgenic or knockout/in models, viral models).
- Promoting the study of biomarkers for vascular and immune diseases of the nervous system.
- Strongly encouraging bi-directional translational research that transfers insights gained from basic research and clinical investigations.
Major Program Portfolios include: Stroke
Multiple Sclerosis
Neuro-AIDS
Prion Diseases
Encephalitis NIH-Supported Clinical Trials in Neural Environment Areas: Additional Links Workshops and Summaries Genetics and Multiple Sclerosis: Future Prospects September 8-10, 2003
Astrocyte Function in Health and Disease September 23 - 25, 2002
International Workshop on Brain Banking March 11-12, 2002
NIH Myositis Outcomes Workshop November 9 - 10, 2001
Workshop on Research Opportunities on Human Neuroborreliosis September 9 - 12, 2001
NINDS Health Disparities Planning Panel on NeuroAIDS in Minority Populations July 16, 2001
Multiple Sclerosis and Chemokines: Prospects for Therapeutic and Prophylactic Intervention July 9 - 10, 2001PersonnelTom Jacobs, Ph.D. tj12g@nih.gov Program Director Room NSC 2112 Specialties: Stroke, Blood-brain barrier; Cerebrovascular biology; Astrocyte biology
| | Michael Nunn, Ph.D. mn52e@nih.gov Program Director Room NSC 2115 Specialties: Pathogenesis of HIV; Mechanisms of inflammation and signal transduction
| Audrey Penn, M.D. ap101d@nih.gov NINDS Deputy Director Room NSC 3304 Specialties: Neuromuscular biology and disease; Neuroimmunology
| | Ursula Utz, Ph.D., M.B.A. utzu@ninds.nih.gov Program Director Room NSC 2134 Specialties: Neuroimmunology, including autoimmune diseases such as M.S.
| Karen Bateman, B.S. kb287y@nih.gov Program Analyst Room NSC 2121A
| | Toya Rogers tr129b@nih.gov Program Assistant Room NSC 2111C
| Donald Thompson dt168e@nih.gov Program Assistant Room NSC 2111B
| | Maria Garcia mg421s@nih.gov Program Assistant Room NSC 2111A
| |
|
AddressNeural Environment
Neuroscience Center
Room NSC 2110
6001 Executive Blvd.
Bethesda, Maryland 20892-9521
For courier service only, use Rockville, Maryland 20852
Call: (301) 496-1431
|